Printer Friendly

CYTOGEN WELCOMES MICHAEL PAULIK AS VICE PRESIDENT OF OPERATIONS

 CYTOGEN WELCOMES MICHAEL PAULIK AS VICE PRESIDENT OF OPERATIONS
 PRINCETON, N.J., Sept. 1 /PRNewswire/ -- Cytogen Corporation (NASDAQ: CYTO) announced today the appointment of Michael M. Paulik to the newly created position of vice president of Operations, with responsibilities for Process Development, Quality Services, Engineering, and Materials Management.
 Paulik has more than 25 years of in-depth international and domestic pharmaceutical and biotech experience, including 18 years at Squibb Corporation. His most recent position was senior vice president of Operations for Serono Laboratories, Inc. Paulik will report to President Thomas J. McKearn, M.D., Ph.D.
 Regarding this new appointment, Dr. McKearn said, "The addition of Mike's extensive experience in this highly specialized field is extremely beneficial to Cytogen's long-range strategic plan." Paulik's immediate plans are to further refine and strengthen the organization, facilities, and operating systems of Cytogen, thereby completing the transition to a fully integrated, state of the art, biopharmaceutical entity.
 Cytogen is a biopharmaceutical company engaged in the development of products utilizing monoclonal antibodies for the targeted delivery of diagnostic and therapeutic substances directly to sites of disease. Cytogen uses its patented and proprietary antibody "linker" technology primarily to develop specific cancer diagnostic imaging and cancer therapeutic products.
 /delval/
 -0- 9/1/92
 /CONTACT: Martin D. Cleary, group vice president of Cytogen, 609-987-8221/
 (CYTO) CO: Cytogen Corporation ST: New Jersey IN: MTC SU: PER


MP -- PH006 -- 5281 09/01/92 09:12 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 1, 1992
Words:235
Previous Article:BUICK'S 1993 MODELS INTRODUCED
Next Article:COLUMBIA HOSPITAL CORPORATION ANNOUNCES HURRICANE DAMAGE LIMITED TO ONE HOSPITAL
Topics:


Related Articles
CYTOGEN ANNOUNCES APPOINTMENT OF REGIONAL SALES MANAGERS
CYTOGEN SCIENTISTS HONORED BY R&D COUNCIL OF NEW JERSEY
CYTOGEN ELECTS BRUCE R. ROSS TO BOARD OF DIRECTORS
PAMELA M. MURPHY JOINS CYTOGEN AS VICE PRESIDENT CORPORATE COMMUNICATIONS
CYTOGEN ANNOUNCES ELECTION OF WILLIAM C. MILLS III AS CHAIRMAN OF THE BOARD
DR. ROBERT MAGUIRE PROMOTED TO CYTOGEN VP OF MEDICAL AFFAIRS
CYTOGEN NAMES L. MICHAEL HINDS, PH.D., VICE PRESIDENT SALES AND MARKETING
CYTOGEN BOARD OF DIRECTORS NAMES THOMAS J. MCKEARN AS CHAIRMAN
CYTOGEN Announces Management Additions
Cytogen Appoints Kevin Bratton New Chief Financial Officer.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters